Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $7.2950 (2.6%) ($7.2950 - $7.2950) on Fri. Feb. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.84% (three month average) | RSI | 35 | Latest Price | $7.2950(2.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -2.1% a day on average for past five trading days. | Weekly Trend | AUTL declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(13%) BNDX(12%) LIT(12%) SKYY(12%) IBB(11%) | Factors Impacting AUTL price | AUTL will decline at least -2.42% in a week (0% probabilities). USO(-7%) TBT(-7%) IGOV(-7%) UNG(-5%) VIXM(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.42% (StdDev 4.84%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.31(-213.91%) | Inflection Point | Yes | Resistance Level | $8.04 | 5 Day Moving Average | $7.52(-2.99%) | 10 Day Moving Average | $7.64(-4.52%) | 20 Day Moving Average | $8.04(-9.27%) | To recent high | -38.6% | To recent low | 3.5% | Market Cap | $381m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |